Heparin Sodium, identified by CAS number 9041-08-1, is a complex glycosaminoglycan whose primary function as an anticoagulant is fundamental to modern medicine. The efficacy of Heparin Sodium lies in its precise heparin sodium anticoagulant mechanism. It achieves this by binding to antithrombin, a natural inhibitor in the body. This binding process significantly enhances antithrombin's ability to neutralize key clotting factors, particularly Factor Xa and thrombin (Factor IIa). By doing so, Heparin Sodium effectively prevents the cascade of reactions that lead to the formation of a blood clot.

The heparin sodium chemical properties are central to its therapeutic action. As a highly sulfated polysaccharide, it possesses a strong negative charge that facilitates its interaction with antithrombin and other clotting factors. These properties are meticulously managed by heparin sodium manufacturers to ensure product consistency and efficacy. The availability of reliable suppliers for heparin sodium cas 9041-08-1 manufacturers is crucial for uninterrupted supply chains in healthcare.

The heparin sodium cas 9041-08-1 uses extend across a broad spectrum of medical interventions. It is vital in treating conditions like deep vein thrombosis and pulmonary embolism, and it plays a critical role in preventing clots during surgical procedures, including cardiovascular surgery and kidney dialysis. The article also touches upon heparin sodium medical treatments that rely on its potent anticoagulant properties, highlighting its indispensable nature in critical care.

Understanding the potential heparin sodium side effects, such as bleeding or the rare heparin-induced thrombocytopenia (HIT), is essential. The heparin sodium drug interactions are also a significant area of focus for healthcare professionals to ensure patient safety. While the heparin sodium pregnancy safety is generally favorable, continuous medical oversight is paramount. The consistent quality and reliable supply from heparin sodium manufacturers are fundamental to maintaining these critical medical treatments.